市场调查报告书
商品编码
1451711
2024-2032 年按类型、技术(微阵列、即时定量聚合酶炼式反应、定序技术)、应用、最终用户和地区分類的转录组学市场报告Transcriptomics Market Report by Type, Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies), Application, End User, and Region 2024-2032 |
2023年,全球转录组学市场规模达到72亿美元。展望未来, IMARC Group预计到2032年市场规模将达到118亿美元,2024-2032年复合年增长率(CAGR)为5.44%。
转录组学是对任何生物的基因型在特定时间、条件或细胞产生的核糖核酸 (RNA) 转录本的分析。它将基因组、蛋白质组和细胞表型连结起来。转录组学涵盖与 RNA 相关的一切,包括它们的转录和表达水平、功能、位置、运输和降解。转录组学利用微阵列分析、即时定量聚合酶炼式反应 (Q-PCR) 和定序技术来确定基因的转录结构。它还帮助研究人员表征转录活性,重点关注相关目标基因和转录本的子集,并识别响应和抵消生物和非生物环境胁迫的基因和途径。
全球对个人化医疗的需求不断增长,为市场创造了积极的前景。由于 PCR 应用数量的增加以及该领域的进步(例如 RNA 定序的广泛使用),转录组学得到了广泛的应用。与此一致的是,在研究应用中获取遗传资讯对RNA定序的需求不断增长也有利于市场的成长。 RNA 定序彻底改变了转录组分析,能够在单一研究中量化基因表现水平,以及新基因、剪接亚型、融合转录本的亲和力,以及对非编码 RNA 领域的非凡研究。除此之外,主要参与者不断致力于开发疾病和诊断的新颖仪器和技术,这反过来又促进了市场成长。此外,推出具有全转录组定序 (WTS) 功能的先进基因分析产品,可提供详细的 RNA 定序分析,对市场成长产生了积极影响。除此之外,广泛的研究和开发(R&D)活动、由于Covid-19疾病的爆发而对转录组学的需求不断增加,以及各种政府倡议和组学资金的实施正在支持市场的成长。
The global transcriptomics market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.44% during 2024-2032.
Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.
The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, application and end user.
Instruments
Consumables
Software
Services
Microarray
Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies
Diagnostics and Disease Profiling
Drug Discovery
Others
Academic and Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.